Dawn Lee

Summary

Publications

  1. pmc Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland
    Dawn Lee
    BresMed, North Church House, 84 Queen Street, Sheffield, S1 2DW, UK
    Appl Health Econ Health Policy 11:457-69. 2013
  2. doi The cost effectiveness of licensed oromucosal midazolam (Buccolam(®)) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited
    Dawn Lee
    BresMed, North Church House, 84 Queen Street, Sheffield, S1 2DW, UK
    Paediatr Drugs 15:151-62. 2013
  3. doi A cost-utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom
    Dawn Lee
    Bsc, BresMed, Sheffield, UK
    J Med Econ 17:233-47. 2014

Detail Information

Publications3

  1. pmc Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland
    Dawn Lee
    BresMed, North Church House, 84 Queen Street, Sheffield, S1 2DW, UK
    Appl Health Econ Health Policy 11:457-69. 2013
    ..Clinical trials have shown that romiplostim increases platelet counts, while reducing the risk of bleeding and, in turn, the need for costly rescue medications...
  2. doi The cost effectiveness of licensed oromucosal midazolam (Buccolam(®)) for the treatment of children experiencing acute epileptic seizures: an approach when trial evidence is limited
    Dawn Lee
    BresMed, North Church House, 84 Queen Street, Sheffield, S1 2DW, UK
    Paediatr Drugs 15:151-62. 2013
    ..This can lead to challenges when conducting economic evaluations...
  3. doi A cost-utility analysis of degarelix in the treatment of advanced hormone-dependent prostate cancer in the United Kingdom
    Dawn Lee
    Bsc, BresMed, Sheffield, UK
    J Med Econ 17:233-47. 2014
    ....